Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor Umansky

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Oncoimmunology|August 31, 2012
New strategies for melanoma immunotherapy: How to overcome immunosuppression in the tumor microenvironmentViktor Umansky
Seminars in Cancer Biology|June 20, 2012
Immunosuppression in the tumor microenvironment: where are we standing?Viktor Umansky
Immunotherapy|July 20, 2010
The 3rd International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): meeting highlights. 11-13 November, 2009, Dublin, IrelandViktor Umansky
Journal of Cancer|February 7, 2013
Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thievesAlexandra Sevko, Viktor Umansky
Seminars in Cancer Biology|February 22, 2012
Melanoma-induced immunosuppression and its neutralizationViktor Umansky, Alexandra Sevko
Journal of Leukocyte Biology|January 19, 2018
Editorial: Two MDSC faces in obesity: Correcting metabolic dysfunctions but promoting tumor developmentViktor Fleming, Viktor Umansky
Pigment Cell & Melanoma Research|April 9, 2013
Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cellsViktor Umansky, Alexandra Sevko
Cancer Immunology, Immunotherapy : CII|November 29, 2011
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammationViktor Umansky, Alexandra Sevko
The Journal of Clinical Investigation|September 5, 2019
Fighting infant infections with myeloid-derived suppressor cellsRebekka Weber, Viktor Umansky
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|December 18, 2012
Tumor microenvironment and myeloid-derived suppressor cellsViktor Umansky, Alexandra Sevko
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Oncoimmunology|August 31, 2012
New strategies for melanoma immunotherapy: How to overcome immunosuppression in the tumor microenvironmentViktor Umansky
Seminars in Cancer Biology|June 20, 2012
Immunosuppression in the tumor microenvironment: where are we standing?Viktor Umansky
Immunotherapy|July 20, 2010
The 3rd International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): meeting highlights. 11-13 November, 2009, Dublin, IrelandViktor Umansky
Journal of Cancer|February 7, 2013
Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thievesAlexandra Sevko, Viktor Umansky
Seminars in Cancer Biology|February 22, 2012
Melanoma-induced immunosuppression and its neutralizationViktor Umansky, Alexandra Sevko
Journal of Leukocyte Biology|January 19, 2018
Editorial: Two MDSC faces in obesity: Correcting metabolic dysfunctions but promoting tumor developmentViktor Fleming, Viktor Umansky
Pigment Cell & Melanoma Research|April 9, 2013
Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cellsViktor Umansky, Alexandra Sevko
Cancer Immunology, Immunotherapy : CII|November 29, 2011
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammationViktor Umansky, Alexandra Sevko
The Journal of Clinical Investigation|September 5, 2019
Fighting infant infections with myeloid-derived suppressor cellsRebekka Weber, Viktor Umansky
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|December 18, 2012
Tumor microenvironment and myeloid-derived suppressor cellsViktor Umansky, Alexandra Sevko
Pageof 16